Companies: 10,795·Total market cap: $144.5T
iCAD, Inc.

iCAD, Inc.

ICADNASDAQHealthcare
$3.87
+$0.14(+3.75%)
Market Cap$106312383
P/E Ratio
52W High$4.01
52W Low$1.19
SEC Filings

iCAD, Inc. (ICAD) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000749660 · ICAD · NASDAQ · as of Jun 9, 2026

Filing snapshot

1,000+
Total Filings
SCHEDULE 13G/A
Latest Form
2025-11-10
Most Recent
1984
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0000749660 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-04-30
Fiscal Year End
Apr 30, 2025
Accession No.
0001193805-25-000588
Primary Document
e664438_10ka-icad.htm
Source: data.sec.gov · CIK 0000749660 · Accession 0001193805-25-000588

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2025-05-13
8-KCurrent Report
Current Report
2025-07-17Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-11-10
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-08-12
View
15-12G15-12G
NOTICE OF TERMINATION
2025-07-28
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
EFFECTEFFECT
EFFECT
2025-07-21
View
S-8 POSS-8 POS
POST EFFECTIVE AMENDMENT TO S-8
2025-07-17
View
S-8 POSS-8 POS
POST EFFECTIVE AMENDMENT TO S-8
2025-07-17
View
Showing 1–15 of 463 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000749660  |  Exchange: NASDAQ · Healthcare

iCAD, Inc. (NASDAQ: ICAD) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1984. As a Healthcare sector company with CIK 0000749660, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is iCAD, Inc.'s most comprehensive regulatory disclosure. The most recent iCAD, Inc. 10-K was filed on 2025-04-30 for fiscal year ending 2025. Historical ICAD 10-K annual reports are available from 2009 through 2025.

Investors researching iCAD, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

ICAD SEC Filings · 8 questions

iCAD, Inc. (ICAD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. iCAD, Inc.'s CIK is 0000749660.

ICAD SEC filingsiCAD, Inc. SEC documentsfind ICAD 10-K